$0.94
+0.08 (+9.38%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,076.4% upside
Low Target
$6.75
Average Target
$11.07
High Target
$12.78
Current Price
$0.94
Current
$0.94
$0.94
Target
$11.07
$11.07
$6.75
$11.07 avg
$12.78
Scenario Analysis
Bear Case
$6.75
617.3%
Low target
Base Case
$11.07
+1,076.4%
Avg target
Bull Case
$12.78
+1,258.1%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$2.50
-62.4% from high
52-Week Low
$0.50
+88.2% from low
Target vs 52W High
$11.07
+342.8% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +3.3% |
| AMGN | Hold | 43 | 49% | $190.87 | -54.0% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.1% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -13.3% |
| REGN | Buy | 37 | 70% | $76.80 | -90.4% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -53.9% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.0% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.4% |